Improved survival in AML with higher anthracycline doses
Author: Tamer M. Fouad, M.D.
Submitted: September 29, 2009. Updated: September 29, 2009.
Category: Hematology | Bone Marrow Transplantation | Oncology | Pharmacy
Younger patients with acute myeloid leukemia (AML) that receive higher doses of anthracyclines during induction chemotherapy are reported to have better complete remission rates in most studies. As of yet, studies have failed to show an improved surivival…
Read more... (Comments: 0)
Heparin Induced Thrombocytopenia - more common than believed
Author: Parks P, RN
Submitted: July 10, 2009. Updated: September 21, 2009.
Category: Family Medicine | Hematology | Nursing
Heparin induced thrombocytopenia (HIT) is a severe immune reaction to heparin. Heparin is the most common prescribed anticoagulant in the United States. HIT is a potentially fatal condition it can lead to amputation and loss of limbs; it is more common…
Read more... (Comments: 1)